Grupo Aval Acciones (NYSE:AVAL) Stock, Quote.Headers.trade-ideas

Grupo Aval Acciones

Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its local operations consist of commercial banking (Banco de Bogota, Banco de Occidente, Banco Popular, and Banco AV Villas), pension fund management (Porvenir), and merchant banking (Corficolombiana). Outside Colombia, the company offers (via BAC Credomatic operations) consumer and credit card banking businesses in Central American countries (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama) and Mexico. BAC Credomatic has key alliances with major credit card networks, such as Visa, MasterCard, American Express, and Diners Club.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

AVAL

BENF

BLND

CANO

KODK

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MKFG

PGEN

SENS

U.S. stock futures traded mixed this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Cano Health, Maxeon Solar Technologies, Velo3D And Other Big Stocks Moving Lower In Friday&#39;s Pre-Market Session

ACOR

ANGN

ATNF

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BEKE

BGXX

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BlackSky Technology Inc. Class A Common Stock

BKSY

BORR

BSGM

BTCY

BZFD

CLDX

CPOP

DRRX

New Oriental Education & Technology Group

ELEV

FAMI

GMBL

GRAB

HUSA

ICVX

IKNA

IMMX

INDO

JCSE

KIRK

LXEH

MARPS

MCLD

MITO

MLTX

MSPR

MSTR

MULN

MYGN

NEXI

NTCT

OPGN

OTLK

PDSB

PEGY

PGRU

PMVP

PPIH

PRPL

PSHG

REDU

RMTI

RSLS

SANG

SASI

SESN

SIGA

SLHG

SMMT

SNMP

TALS

TGTX

TXMD

VNTR

WISA

XELB

Gainers


	TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.


77 Biggest Movers From Yesterday

Intraday Update

ABMD

ACBI

ACCO

ACEL

ACGL

ADOM

AERI

AGEN

AIRG

ALEX

ALLE

ALSN

AMCX

ANTM

AOSL

APYX

AQUA

ARCW

ARES

ARNC

ASRV

ASTC

ATEC

ATHM

ATRS

ATTO

AUTO

AVNS

AWSM

AZPN

BANR

BBDO

BCOR

BCSF

BDSI

BECN

BFST

BHLB

BKNG

BMRC

BNED

BOKF

Stocks That Hit 52-Week Lows On Monday

Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)

Grupo Aval Acciones y Valores SA

AVALON CORRECTIONAL INC by Avalon Correctional Services, Inc.

AVALONBAY COMMUNITIES REIT ORD

Avalanche - United States Dollar

AVALANCHE INTL CORP by Avalanche International Corp

Avalanche International Corp

Avalaunch - United States Dollar

Avalo Therapeutics Inc

AVALON ADVANCED MATERIALS by Avalon Advanced Materials Inc.

Avalon Advanced Materials Inc

Avalon Globocare Corp

Avalon Holdings Corp

AvalonBay Communities Inc

Grupo Aval Acciones (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVAL#NYSE">AVAL</a>) is set to give its latest quarterly earnings report on Wednesday, 2023-11-15. Here's what investors need to know before the announcement.
Analysts estimate that Grupo Aval Acciones will report an earnings per share (EPS) of $0.08. 
Grupo Aval Acciones bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here's a look at Grupo Aval Acciones's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.61</td>
<td>0.08</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.54%</td>
<td>-7.46%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of Grupo Aval Acciones were trading at $2.2278 as of November 13. Over the last 52-week period, shares are up 1.1%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/AVAL/earnings">To track all earnings releases for Grupo Aval Acciones visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Earnings Preview For Grupo Aval Acciones

<h3>Upgrades</h3>
UBS upgraded the previous rating for Aemetis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMTX#NASDAQ">AMTX</a>) from Neutral to Buy. For the second quarter, Aemetis had an EPS of $0.68, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $10.74 and a 52-week-low of $1.16. At the end of the last trading period, Aemetis closed at $6.16. 
According to Exane BNP Paribas, the prior rating for Revance Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) was changed from Underperform to Neutral. In the second quarter, Revance Therapeutics showed an EPS of $0.80, compared to $0.88 from the year-ago quarter. The current stock performance of Revance Therapeutics shows a 52-week-high of $37.98 and a 52-week-low of $17.97. Moreover, at the end of the last trading period, the closing price was at $18.80. 
For Inter &amp; Co Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTR#NASDAQ">INTR</a>), Citigroup upgraded the previous rating of Neutral to Buy. For the second quarter, Inter &amp; Co had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $4.63 and a 52-week-low of $1.37. Inter &amp; Co closed at $3.94 at the end of the last trading period. 
Evercore ISI Group upgraded the previous rating for Magnite Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) from In-Line to Outperform. For the second quarter, Magnite had an EPS of $0.09, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $15.73 and a 52-week-low of $5.58. Magnite closed at $8.52 at the end of the last trading period. 
For National CineMedia Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCMI#NASDAQ">NCMI</a>), Benchmark upgraded the previous rating of Hold to Speculative Buy. National CineMedia earned $0.08 in the fourth quarter, compared to $0.05 in the year-ago quarter. The current stock performance of National CineMedia shows a 52-week-high of $18.20 and a 52-week-low of $1.01. Moreover, at the end of the last trading period, the closing price was at $3.55. 
JP Morgan upgraded the previous rating for Gulfport Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) from Neutral to Overweight. In the second quarter, Gulfport Energy showed an EPS of $2.66, compared to $5.09 from the year-ago quarter. The current stock performance of Gulfport Energy shows a 52-week-high of $114.88 and a 52-week-low of $60.15. Moreover, at the end of the last trading period, the closing price was at $112.23. 
JP Morgan upgraded the previous rating for SM Energy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) from Neutral to Overweight. For the second quarter, SM Energy had an EPS of $1.28, compared to year-ago quarter EPS of $2.19. The current stock performance of SM Energy shows a 52-week-high of $48.54 and a 52-week-low of $24.66. Moreover, at the end of the last trading period, the closing price was at $39.01. 
According to JP Morgan, the prior rating for Pioneer Natural Resources Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PXD#NYSE">PXD</a>) was changed from Neutral to Overweight. In the second quarter, Pioneer Natural Resources showed an EPS of $4.49, compared to $9.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $274.42 and a 52-week-low of $177.26. Pioneer Natural Resources closed at $233.72 at the end of the last trading period. 
BMO Capital upgraded the previous rating for CareTrust REIT Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRE#NYSE">CTRE</a>) from Market Perform to Outperform. In the second quarter, CareTrust REIT showed an EPS of $0.35, compared to $0.37 from the year-ago quarter. The current stock performance of CareTrust REIT shows a 52-week-high of $22.09 and a 52-week-low of $16.22. Moreover, at the end of the last trading period, the closing price was at $19.89. 
According to Citigroup, the prior rating for Callon Petroleum Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPE#NYSE">CPE</a>) was changed from Neutral to Buy. In the second quarter, Callon Petroleum showed an EPS of $1.99, compared to $3.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $50.10 and a 52-week-low of $28.91. Callon Petroleum closed at $35.59 at the end of the last trading period. 
According to Mizuho, the prior rating for Permian Resources Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PR#NYSE">PR</a>) was changed from Neutral to Buy. At the moment, the stock has a 52-week-high of $12.62 and a 52-week-low of $6.12. Permian Resources closed at $12.16 at the end of the last trading period. 
According to Mizuho, the prior rating for Matador Resources Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTDR#NYSE">MTDR</a>) was changed from Neutral to Buy. In the second quarter, Matador Resources showed an EPS of $1.42, compared to $3.47 from the year-ago quarter. The current stock performance of Matador Resources shows a 52-week-high of $73.76 and a 52-week-low of $42.04. Moreover, at the end of the last trading period, the closing price was at $57.82. 
For Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), Mizuho upgraded the previous rating of Neutral to Buy. For the second quarter, Chevron had an EPS of $3.08, compared to year-ago quarter EPS of $5.82. At the moment, the stock has a 52-week-high of $189.66 and a 52-week-low of $140.48. Chevron closed at $159.24 at the end of the last trading period. 
For NextDecade Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the first quarter, NextDecade had an EPS of $0.23, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $8.94 and a 52-week-low of $3.92. NextDecade closed at $5.91 at the end of the last trading period. 
According to Goldman Sachs, the prior rating for Brixmor Property Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRX#NYSE">BRX</a>) was changed from Neutral to Buy. Brixmor Property Group earned $0.52 in the second quarter, compared to $0.49 in the year-ago quarter. The stock has a 52-week-high of $24.49 and a 52-week-low of $17.62. At the end of the last trading period, Brixmor Property Group closed at $22.21. 
According to UBS, the prior rating for Keurig Dr Pepper Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) was changed from Neutral to Buy. For the second quarter, Keurig Dr Pepper had an EPS of $0.42, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $41.25 and a 52-week-low of $30.47. At the end of the last trading period, Keurig Dr Pepper closed at $33.47. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
<h3>Downgrades</h3>
According to B of A Securities, the prior rating for SolarEdge Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) was changed from Buy to Neutral. SolarEdge Technologies earned $2.62 in the second quarter, compared to $0.95 in the year-ago quarter. The current stock performance of SolarEdge Technologies shows a 52-week-high of $345.80 and a 52-week-low of $169.86. Moreover, at the end of the last trading period, the closing price was at $170.00. 
HC Wainwright &amp; Co. downgraded the previous rating for Alaunos Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) from Buy to Neutral. For the second quarter, Alaunos Therapeutics had an EPS of $0.04, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $4.01 and a 52-week-low of $0.12. At the end of the last trading period, Alaunos Therapeutics closed at $0.14. 
For Magellan Midstream Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMP#NYSE">MMP</a>), Argus Research downgraded the previous rating of Hold to Sell. Magellan Midstream earned $1.23 in the second quarter, compared to $1.17 in the year-ago quarter. The stock has a 52-week-high of $66.78 and a 52-week-low of $45.55. At the end of the last trading period, Magellan Midstream closed at $65.55. 
According to DA Davidson, the prior rating for Southland Holdings Inc (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SLND#AMEX">SLND</a>) was changed from Buy to Neutral. At the moment, the stock has a 52-week-high of $10.85 and a 52-week-low of $5.66. Southland Holdings closed at $6.41 at the end of the last trading period. 
For Marqeta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>), BTIG downgraded the previous rating of Neutral to Sell. For the second quarter, Marqeta had an EPS of $0.11, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $8.71 and a 52-week-low of $3.46. At the end of the last trading period, Marqeta closed at $5.88. 
For Galera Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>), HC Wainwright &amp; Co. downgraded the previous rating of Buy to Neutral. Galera Therapeutics earned $0.48 in the second quarter, compared to $0.54 in the year-ago quarter. The current stock performance of Galera Therapeutics shows a 52-week-high of $3.59 and a 52-week-low of $0.25. Moreover, at the end of the last trading period, the closing price was at $0.27. 
For Chesapeake Energy Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHK#NASDAQ">CHK</a>), JP Morgan downgraded the previous rating of Overweight to Neutral. For the second quarter, Chesapeake Energy had an EPS of $0.64, compared to year-ago quarter EPS of $4.87. At the moment, the stock has a 52-week-high of $107.31 and a 52-week-low of $69.68. Chesapeake Energy closed at $82.87 at the end of the last trading period. 
According to Mizuho, the prior rating for Magnolia Oil &amp; Gas Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGY#NYSE">MGY</a>) was changed from Buy to Neutral. In the second quarter, Magnolia Oil &amp; Gas showed an EPS of $0.51, compared to $1.32 from the year-ago quarter. The stock has a 52-week-high of $27.54 and a 52-week-low of $18.17. At the end of the last trading period, Magnolia Oil &amp; Gas closed at $22.68. 
According to Mizuho, the prior rating for HF Sinclair Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DINO#NYSE">DINO</a>) was changed from Buy to Neutral. In the second quarter, HF Sinclair showed an EPS of $2.60, compared to $5.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $66.17 and a 52-week-low of $37.12. HF Sinclair closed at $55.77 at the end of the last trading period. 
For Marathon Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>), Mizuho downgraded the previous rating of Buy to Neutral. In the second quarter, Marathon Petroleum showed an EPS of $5.32, compared to $10.61 from the year-ago quarter. At the moment, the stock has a 52-week-high of $149.76 and a 52-week-low of $89.41. Marathon Petroleum closed at $142.62 at the end of the last trading period. 
According to RBC Capital, the prior rating for Easterly Government Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) was changed from Sector Perform to Underperform. In the second quarter, Easterly Government Props showed an EPS of $0.28, compared to $0.33 from the year-ago quarter. The current stock performance of Easterly Government Props shows a 52-week-high of $19.41 and a 52-week-low of $12.27. Moreover, at the end of the last trading period, the closing price was at $14.22. 
According to Canaccord Genuity, the prior rating for Zynerba Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYNE#NASDAQ">ZYNE</a>) was changed from Buy to Hold. Zynerba Pharmaceuticals earned $0.21 in the second quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $1.38 and a 52-week-low of $0.25. Zynerba Pharmaceuticals closed at $1.35 at the end of the last trading period. 
For Golar LNG Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLNG#NASDAQ">GLNG</a>), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the second quarter, Golar LNG showed an EPS of $0.04, compared to $2.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $30.65 and a 52-week-low of $19.62. Golar LNG closed at $22.39 at the end of the last trading period. 
According to JP Morgan, the prior rating for Grupo Aval Acciones y Valores SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVAL#NYSE">AVAL</a>) was changed from Neutral to Underweight. Grupo Aval Acciones earned $0.08 in the third quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.48 and a 52-week-low of $2.02. Grupo Aval Acciones closed at $2.45 at the end of the last trading period. 
According to Goldman Sachs, the prior rating for Kimco Realty Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>) was changed from Buy to Neutral. In the second quarter, Kimco Realty showed an EPS of $0.39, compared to $0.40 from the year-ago quarter. The stock has a 52-week-high of $23.89 and a 52-week-low of $17.34. At the end of the last trading period, Kimco Realty closed at $19.81. 
According to Goldman Sachs, the prior rating for Tanger Factory Outlet Centers Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKT#NYSE">SKT</a>) was changed from Buy to Neutral. For the second quarter, Tanger Factory Outlet had an EPS of $0.47, compared to year-ago quarter EPS of $0.45. The stock has a 52-week-high of $25.23 and a 52-week-low of $13.26. At the end of the last trading period, Tanger Factory Outlet closed at $24.57. 
Keefe, Bruyette &amp; Woods downgraded the previous rating for CB Financial Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBFV#NASDAQ">CBFV</a>) from Outperform to Market Perform. For the second quarter, CB Financial Services had an EPS of $0.63, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $24.98 and a 52-week-low of $17.20. At the end of the last trading period, CB Financial Services closed at $22.67. 
According to Citigroup, the prior rating for Sea Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) was changed from Buy to Neutral. In the second quarter, Sea showed an EPS of $0.54, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $92.20 and a 52-week-low of $40.11. At the end of the last trading period, Sea closed at $40.58. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h3>Initiations</h3>
Capital One initiated coverage on Immunocore Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) with an Overweight rating. The price target for Immunocore Hldgs is set to $84.00. For the second quarter, Immunocore Hldgs had an EPS of $0.37, compared to year-ago quarter EPS of $0.17. At the moment, the stock has a 52-week-high of $69.01 and a 52-week-low of $39.00. Immunocore Hldgs closed at $60.25 at the end of the last trading period. 
With an Overweight rating, Wells Fargo initiated coverage on GE HealthCare Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>). The price target seems to have been set at $90.00 for GE HealthCare Techs. For the second quarter, GE HealthCare Techs had an EPS of $0.92, compared to year-ago quarter EPS of $1.15. The stock has a 52-week-high of $87.83 and a 52-week-low of $53.00. At the end of the last trading period, GE HealthCare Techs closed at $70.54. 
Barclays initiated coverage on Fortrea Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) with a Equal-Weight rating. The price target for Fortrea Holdings is set to $29.00. For the second quarter, Fortrea Holdings had an EPS of $0.52, compared to year-ago quarter EPS of $0.97. At the moment, the stock has a 52-week-high of $37.30 and a 52-week-low of $25.68. Fortrea Holdings closed at $27.18 at the end of the last trading period. 
With a Buy rating, Guggenheim initiated coverage on Vera Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>). The price target seems to have been set at $27.00 for Vera Therapeutics. For the second quarter, Vera Therapeutics had an EPS of $0.46, compared to year-ago quarter EPS of $0.55. The current stock performance of Vera Therapeutics shows a 52-week-high of $23.29 and a 52-week-low of $5.20. Moreover, at the end of the last trading period, the closing price was at $17.69. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Analyst Ratings

AMTX

CBFV

CTRE

DINO

FTRE

GEHC

GLNG

GPOR

GRTX

IMCR

INTR

MGNI

MTDR

NCMI

RVNC

SEDG

SLND

TCRT

VERA

ZYNE

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023

JP Morgan analyst Yuri Fernandes downgrades Grupo Aval Acciones (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVAL#NYSE">AVAL</a>) from Neutral to Underweight.

JP Morgan Downgrades Grupo Aval Acciones to Underweight

U.S. stock futures traded mixed this morning on Friday. Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) shares tumbled 41.5% to $0.89 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/maxn#NASDAQ">MAXN</a>) shares dipped 25.7% to $16.55 in pre-market trading after the company reported mixed second-quarter financial results and issued FY23 revenue guidance below estimates.</li>
<li>Markforged Holding Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkfg#NYSE">MKFG</a>) fell 8.5% to $1.40 in pre-market trading following second-quarter results.</li>
<li>Grupo Aval Acciones y Valores S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aval#NYSE">AVAL</a>) fell 8.3% to $2.42 in pre-market trading.</li>
<li>Velo3D, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vld#NYSE">VLD</a>) shares fell 7.7% to $1.67 in pre-market trading after the company reported worse-than-expected second-quarter financial results and announced an offering of $70 million of senior secured convertible notes.</li>
<li>Blend Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NYSE">BLND</a>) shares declined 7.7% to $1.32 in pre-market trading. Blend Labs shares gained 17% on Thursday after the company reported better-than-expected second-quarter financial results and issued third-quarter consolidated revenue guidance.</li>
<li>Senseonics Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sens#NYSE">SENS</a>) shares fell 7.5% to $0.6818 in pre-market trading following weak quarterly sales.</li>
<li>Eastman Kodak Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kodk#NYSE">KODK</a>) fell 6.3% to $4.48 in pre-market trading.</li>
<li>Beneficient (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/benf#NASDAQ">BENF</a>) shares fell 6.3% to $2.24 in pre-market trading after jumping 28% on Thursday.</li>
<li>Precigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgen#NASDAQ">PGEN</a>) shares declined 5.3% to $1.44 in pre-market trading. Precigen shares gained over 22% on Thursday after the company announced FDA confirmation that the ongoing Phase 1/2 study of PRGN-2012 AdenoVerse Immunotherapy will serve as the pivotal study to support accelerated approval.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/08/33737861/fear-greed-index-remains-in-greed-zone-following-inflation-data"> Fear &amp; Greed Index Remains In &#39;Greed&#39; Zone Following Inflation Data</a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Cano Health, Maxeon Solar Technologies, Velo3D And Other Big Stocks Moving Lower In Friday's Pre-Market Session

WIIM

BSBR

CRBG

EWBC

FCNCA

FITB

INDB

ITUB

KNSL

LPLA

PACW

SCHW

SFBS

UMBF

Shares of banking and financial services companies are trading higher amid renewed economic optimism following US Senate passage of a debt limit bill and strong US jobs data.

HMST

MEGL

NCPL

SIEB

Shares of several banks and other broader financial stocks are trading lower amid weakness in the space stemming from First Republic Bank after the FDIC confirmed the bank's deposits and assets will be sold to JPMorgan.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Grupo Aval Acciones

Grupo Aval Acciones (AVAL) Forecast

Grupo Aval Acciones (NYSE:AVAL) Stock, Quote.Headers.trade-ideas